Physician profile
Graham R Hurvitz
NPI 1104858620
$95,891.74
in general payments reported to CMS, 2019-2025
33 companies · $6,358 in 2025
The $6,358 reported for 2025 was more than what 84% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $7,037 · 2021: $11K · 2022: $26K · 2023: $15K · 2024: $9,305 · 2025: $6,358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $20K · Food and Beverage: $7,370 · Consulting Fee: $3,665 · Entertainment: $18.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $20,101.86 |
| Food and Beverage | $7,369.90 |
| Consulting Fee | $3,665.00 |
| Entertainment | $18.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lima USA, INC. | $56,687.23 | 2019-2023 | Smr Shoulder, Lantern Surgical Assistant, Delta Cup |
| Limacorporate S.P.A. | $19,208.24 | 2019-2024 | Physica System |
| Medacta USA, INC. | $7,650.43 | 2019-2024 | |
| Smith+Nephew, INC. | $4,445.76 | 2022-2025 | Real Intelligence, Journey II, Ri Hip Navigation |
| Ortho Development Corporation | $2,814.27 | 2025 | |
| Uoc USA INC | $887.14 | 2022-2024 | U2 Press-Fit, Knee Tensioner, Psi and Ustar II, U2, Conformity, Resolve, Ustar II, Conformity and U2 Press-Fit |
| Stryker Corporation | $675.44 | 2023-2025 | Profyle, Pangea, Prostep Mica |
| Pacira Therapeutics, INC. | $622.26 | 2019-2021 | |
| Medtronic, INC. | $565.88 | 2021-2025 | Aquamantys(Tm), Affera Mapping System |
| Illuminoss Medical, INC. | $207.00 | 2024 | |
| Curonix LLC | $202.26 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Next Science LLC | $195.95 | 2021 | |
| Microport Orthopedics INC | $184.22 | 2020 | |
| Maxx Orthopedics, INC. | $183.78 | 2023-2024 | |
| Miach Orthopaedics, INC. | $170.42 | 2025 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linkbio Corp | $158.68 | 2023 | |
| Linvatec Corporation | $138.15 | 2025 | Biobrace 23mm |
| Heron Therapeutics, INC. | $125.27 | 2023-2025 | Zynrelef |
| Zimmer Biomet Holdings, INC. | $120.28 | 2020 | |
| Orthofix Medical, INC. | $93.51 | 2024 | Accelstim, Physio-Stim |
| Innovation Technologies INC | $89.36 | 2024 | Irrisept |
| Pacira Pharmaceuticals Incorporated | $87.64 | 2024-2025 | Zilretta, Exparel |
| Cornerstone Medical Associates, INC. | $76.02 | 2024 | |
| Fx Shoulder Solutions, INC | $64.44 | 2024 | |
| Djo, LLC | $53.33 | 2023-2024 | Procare, Aircast, Donjoy |
| Fidia Pharma USA INC. | $42.53 | 2019-2022 | |
| Convatec INC. | $38.12 | 2025 | |
| Depuy Synthes Sales INC. | $27.15 | 2022 | |
| Overture Orthopaedics | $18.53 | 2025 | Overtureti |
| Alafair Biosciences, INC. | $15.40 | 2024 | Versawrap |
| Avanos Medical | $15.31 | 2023 | Trivisc Sodium Hyaluronate |
| Ferring Pharmaceuticals INC. | $14.55 | 2025 | Euflexxa |
| Encore Medical, Lp | $13.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5,002.56 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Graham Hurvitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.